Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bogdanova, AtanasovfiledCriticalBogdanova
Priority to BG96407ApriorityCriticalpatent/BG60950B1/en
Publication of BG96407ApublicationCriticalpatent/BG96407A/en
Publication of BG60950B1publicationCriticalpatent/BG60950B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The medicaments can be used for local treatment of wounds caused from burns, radiation impairments and chemical lesions, for the treatment of atrophic and acute inflammatory processes and for pre-operative preparation of open wounds. It is a mixture of yeast transport RNA and bovine timus DNA in ratio from 1.5 to 2.5:1 in the form of a solution of gel in quantities from 0.2 to 0.3% wt.%.
BG96407A1992-06-011992-06-01Medicamentous form for wounds and skin impairments
BG60950B1
(en)
Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon